[1] SWERDLOW S H,HARRIS N L,JAFFE E S,et al.WHO classification of tumours of haematopoietic and lymphoid tissues.WHO classification of tumours[M].4th ed.Lyon:IARC,2017:266-279.
[2] ALAGGIO R,AMADOR C,ANAGNOSTOPOULOS I,et al.The 5th edition of the world health organization classification of haematolymphoid tumours:lymphoid neoplasms[J].Leukemia,2022,36(7):1720-1748.
[3] 张梅,史传兵,张喆.102例血管免疫母细胞性T细胞淋巴瘤的临床病理学特征分析[J].东南大学学报(医学版),2023,42(3):446-451.
[4] 杜则玲,候宁,张喆.12例卵巢原发性淋巴瘤临床病理学研究[J].现代医学,2023,51(12):1674-1679.
[5] LV L,QI X,WANG C,et al.Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis[J].Clin Exp Med,2023,23(6):2675-2685.
[6] KURZ K S,KALMBACH S,OTT M,et al.Follicular lymphoma in the 5th edition of the WHO-classification of haematolymphoid neoplasms-updated classification and new biological data[J].Cancers (Basel),2023,15(3):785.
[7] TAKATA K,SATO Y,NAKAMURA N,et al.Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics[J].Mod Pathol,2013,26(1):22-31.
[8] MARKS E,SHI Y.Duodenal-type follicular lymphoma:a clinicopathologic review[J].Arch Pathol Lab Med,2018,142(4):542-547.
[9] SAITO M,MORI A,TSUKAMOTO S,et al.Duodenal-type follicular lymphoma more than 10 years after treatment intervention:a retrospective single-center analysis[J].World J Gastrointest Oncol,2022,14(8):1552-1561.
[10] LEE H,OH D,YANG K,et al.Radiation therapy outcome and clinical features of duodenal-type follicular lymphoma[J].Cancer Res Treat,2019,51(2):547-555. |